Healthcare Spending Among Community-dwelling Adults With SchizophreniaByMargaret McDonald, PhD,Robin P. Hertz, PhD,Michael B. Lustik, MS,Alan N. Unger, PhDSeptember 15th 2005
Impact of Atypical Antipsychotics on Outcomes of Care in SchizophreniaByAmie T. Joyce, MPH,David J. Harrison, PhD,Antony D. Loebel, MD,Daniel A. Ollendorf, MPHSeptember 15th 2005
Atypical Antipsychotics: Considerations for Medicaid CoverageByRichard C. Surles, PhDSeptember 15th 2005
